Skip to main content

Table 2 The impact of embryo biopsy on neonatal outcome in liveborn children

From: Cleavage-stage or blastocyst-stage embryo biopsy has no impact on growth and health in children up to 2 years of age

 

EBD5 FET

N=222

EBD3 FET

N=322

EBD3 FRESH

N=308

Non-biopsy FET

N=751

Non-biopsy FRESH

N=781

EBD5 FET vs Non-Biopsy FET

EBD3 FET vs Non-Biopsy FET

EBD3 FRESH vs Non-Biopsy FRESH

      

Adjusteda OR (95%CI)

Adjusteda OR (95%CI)

Adjusteda OR (95%CI)

Male sex

108 (48.6)

158 (49.1)

159 (51.6)

373 (49.7)

383 (49.0)

   

Gestational age (weeks) (mean, SD)

39.0 (2.2)

39.2 (1.6)

38.9 (1.7)

39.1 (1.8)

38.9 (1.9)

   

Premature birth <37weeks

15 (6.8)

26 (8.1)

23 (7.5)

69 (9.2)

57 (7.3)

1.00 [0.53, 1.88]

1.08 [0.65, 1.80]

1.08 [0.61, 1.91]

SGA <-1.28 SDS

5 (2.3)

7 (2.2)

14 (4.5)

21 (2.8)

33 (4.2)

1.16 [0.40, 3.40]

0.94 [0.36, 2.41]

1.44 [0.69, 3.00]

LGA >+1.28 SDS

8 (4.0)

13 (4.4)

8 (2.7)

29 (4.1)

10 (1.4)

0.91 [0.29, 1.21]

1.19 [0.57, 2.49]

2.17 [0.71, 6.54]

Low birth weight <2500g

12 (5.4)

14 (4.3)

21 (6.8)

42 (5.6)

53 (6.8)

1.02 [0.33,3.12]

0.87 [0.44, 1.73]

1.24 [0.70, 2.22]

Macrosomia >4000g

29 (13.1)

51 (15.8)

34 (11.0)

82 (10.9)

40 (5.1)

1.01 [0.60, 1.72]

1.42 [0.94, 2.15]

2.31 [1.35, 3.97]*

Major congenital malformations

5/204 (2.5)

13/301 (4.3)

13/292 (4.5)

23/687 (3.3)

26/713 (3.6)

0.93 [0.31, 2.80]

1.91 [0.86, 4.23]

1.22 [0.56, 2.65]

  1. Values are expressed as number and percentage unless otherwise mentioned
  2. EBD5 Embryo Biopsy Day 5, EBD3 Embryo Biopsy Day 3, FRESH fresh embryo transfer, FET frozen-thawed embryo transfer
  3. aadjusted for neonatal (child’s sex), treatment (number of oocytes at pick-up), maternal characteristics (nulliparity, age, BMI, smoking, alcohol, pregnancy-induced hypertensive disorder, gestational diabetes)
  4. *P<0.05